Toromont Industries Ltd. (TMTNF)
OTCMKTS · Delayed Price · Currency is USD
100.36
-1.32 (-1.30%)
Aug 1, 2025, 9:40 AM EDT
CTI BioPharma Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 5,111 | 5,021 | 4,622 | 4,115 | 3,887 | 3,479 | Upgrade | |
Revenue Growth (YoY) | 6.99% | 8.63% | 12.32% | 5.89% | 11.72% | -5.43% | Upgrade |
Cost of Revenue | 3,845 | 3,759 | 3,377 | 2,997 | 2,917 | 2,643 | Upgrade |
Gross Profit | 1,266 | 1,263 | 1,245 | 1,119 | 969.77 | 835.75 | Upgrade |
Selling, General & Admin | 590.97 | 572.76 | 523.76 | 481.42 | 471.03 | 442.11 | Upgrade |
Operating Expenses | 610.67 | 592.46 | 540.66 | 499.42 | 488.83 | 463.31 | Upgrade |
Operating Income | 655.3 | 670.17 | 704.23 | 619.1 | 480.94 | 372.43 | Upgrade |
Interest Expense | -31.95 | -28.66 | -28.1 | -27.33 | -28.16 | -29.98 | Upgrade |
Interest & Investment Income | 43.25 | 53.64 | 45.98 | 21.72 | 9.03 | 9.08 | Upgrade |
EBT Excluding Unusual Items | 666.59 | 695.15 | 722.11 | 613.48 | 461.8 | 351.54 | Upgrade |
Other Unusual Items | - | - | - | - | -5 | - | Upgrade |
Pretax Income | 666.59 | 695.15 | 722.11 | 613.48 | 456.8 | 351.54 | Upgrade |
Income Tax Expense | 180.56 | 188.64 | 193.01 | 163.38 | 124.09 | 96.62 | Upgrade |
Earnings From Continuing Operations | 486.03 | 506.52 | 529.11 | 450.1 | 332.71 | 254.92 | Upgrade |
Earnings From Discontinued Operations | - | - | 5.61 | 4.1 | - | - | Upgrade |
Net Income | 486.03 | 506.52 | 534.71 | 454.2 | 332.71 | 254.92 | Upgrade |
Net Income to Common | 486.03 | 506.52 | 534.71 | 454.2 | 332.71 | 254.92 | Upgrade |
Net Income Growth | -6.34% | -5.27% | 17.73% | 36.52% | 30.52% | -11.12% | Upgrade |
Shares Outstanding (Basic) | 82 | 82 | 82 | 82 | 83 | 82 | Upgrade |
Shares Outstanding (Diluted) | 82 | 83 | 83 | 83 | 83 | 83 | Upgrade |
Shares Change (YoY) | -0.89% | -0.37% | -0.10% | -0.35% | 0.79% | 0.66% | Upgrade |
EPS (Basic) | 5.96 | 6.18 | 6.50 | 5.52 | 4.03 | 3.10 | Upgrade |
EPS (Diluted) | 5.92 | 6.13 | 6.45 | 5.47 | 4.00 | 3.09 | Upgrade |
EPS Growth | -5.66% | -4.93% | 17.89% | 36.73% | 29.45% | -11.46% | Upgrade |
Free Cash Flow | - | 222.71 | 241.32 | 148.4 | 471.52 | 305.74 | Upgrade |
Free Cash Flow Per Share | - | 2.70 | 2.91 | 1.79 | 5.66 | 3.70 | Upgrade |
Dividend Per Share | 2.000 | 1.920 | 1.720 | 1.560 | 1.360 | 1.240 | Upgrade |
Dividend Growth | 9.89% | 11.63% | 10.26% | 14.71% | 9.68% | 14.82% | Upgrade |
Gross Margin | 24.77% | 25.15% | 26.93% | 27.18% | 24.95% | 24.02% | Upgrade |
Operating Margin | 12.82% | 13.35% | 15.24% | 15.04% | 12.37% | 10.71% | Upgrade |
Profit Margin | 9.51% | 10.09% | 11.57% | 11.04% | 8.56% | 7.33% | Upgrade |
Free Cash Flow Margin | - | 4.44% | 5.22% | 3.61% | 12.13% | 8.79% | Upgrade |
EBITDA | 878.3 | 864.02 | 876.31 | 772.03 | 627.66 | 524.86 | Upgrade |
EBITDA Margin | 17.18% | 17.21% | 18.96% | 18.76% | 16.15% | 15.09% | Upgrade |
D&A For EBITDA | 223.01 | 193.85 | 172.08 | 152.93 | 146.73 | 152.43 | Upgrade |
EBIT | 655.3 | 670.17 | 704.23 | 619.1 | 480.94 | 372.43 | Upgrade |
EBIT Margin | 12.82% | 13.35% | 15.24% | 15.04% | 12.37% | 10.71% | Upgrade |
Effective Tax Rate | 27.09% | 27.14% | 26.73% | 26.63% | 27.17% | 27.48% | Upgrade |
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.